0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dutasteride Soft Capsules Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-22O14540
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Dutasteride Soft Capsules Market Research Report 2023
BUY CHAPTERS

Global Dutasteride Soft Capsules Market Research Report 2025

Code: QYRE-Auto-22O14540
Report
May 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Dutasteride Soft Capsules Market

The global market for Dutasteride Soft Capsules was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Dutasteride Soft Capsules is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Dutasteride Soft Capsules is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Dutasteride Soft Capsules include Jiangsu Hengrui Pharmaceuticals Co.,ltd., GlaxoSmithKline plc, Sichuan Gowell Pharmaceutical Co., Ltd., Puracap Pharmaceuticals, Qilu Pharmaceutical Co., Ltd, Rivopharm UK Ltd, DM Pharma Marketing Pvt Ltd, Mega Lifesciences, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dutasteride Soft Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dutasteride Soft Capsules.
The Dutasteride Soft Capsules market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dutasteride Soft Capsules market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dutasteride Soft Capsules manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Dutasteride Soft Capsules Market Report

Report Metric Details
Report Name Dutasteride Soft Capsules Market
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Jiangsu Hengrui Pharmaceuticals Co.,ltd., GlaxoSmithKline plc, Sichuan Gowell Pharmaceutical Co., Ltd., Puracap Pharmaceuticals, Qilu Pharmaceutical Co., Ltd, Rivopharm UK Ltd, DM Pharma Marketing Pvt Ltd, Mega Lifesciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Dutasteride Soft Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Dutasteride Soft Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Dutasteride Soft Capsules Market report?

Ans: The main players in the Dutasteride Soft Capsules Market are Jiangsu Hengrui Pharmaceuticals Co.,ltd., GlaxoSmithKline plc, Sichuan Gowell Pharmaceutical Co., Ltd., Puracap Pharmaceuticals, Qilu Pharmaceutical Co., Ltd, Rivopharm UK Ltd, DM Pharma Marketing Pvt Ltd, Mega Lifesciences

What are the Application segmentation covered in the Dutasteride Soft Capsules Market report?

Ans: The Applications covered in the Dutasteride Soft Capsules Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Dutasteride Soft Capsules Market report?

Ans: The Types covered in the Dutasteride Soft Capsules Market report are Generic Drugs, Original Drugs

Recommended Reports

Soft Capsule Markets

Prescription Drugs

Therapeutic Capsules

1 Dutasteride Soft Capsules Market Overview
1.1 Product Definition
1.2 Dutasteride Soft Capsules by Type
1.2.1 Global Dutasteride Soft Capsules Market Value Comparison by Type (2024 VS 2031)
1.2.2 Generic Drugs
1.2.3 Original Drugs
1.3 Dutasteride Soft Capsules by Application
1.3.1 Global Dutasteride Soft Capsules Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Dutasteride Soft Capsules Market Size Estimates and Forecasts
1.4.1 Global Dutasteride Soft Capsules Revenue 2020-2031
1.4.2 Global Dutasteride Soft Capsules Sales 2020-2031
1.4.3 Global Dutasteride Soft Capsules Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Dutasteride Soft Capsules Market Competition by Manufacturers
2.1 Global Dutasteride Soft Capsules Sales Market Share by Manufacturers (2020-2025)
2.2 Global Dutasteride Soft Capsules Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Dutasteride Soft Capsules Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Dutasteride Soft Capsules, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dutasteride Soft Capsules, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dutasteride Soft Capsules, Product Type & Application
2.7 Global Key Manufacturers of Dutasteride Soft Capsules, Date of Enter into This Industry
2.8 Global Dutasteride Soft Capsules Market Competitive Situation and Trends
2.8.1 Global Dutasteride Soft Capsules Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Dutasteride Soft Capsules Players Market Share by Revenue
2.8.3 Global Dutasteride Soft Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Dutasteride Soft Capsules Market Scenario by Region
3.1 Global Dutasteride Soft Capsules Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Dutasteride Soft Capsules Sales by Region: 2020-2031
3.2.1 Global Dutasteride Soft Capsules Sales by Region: 2020-2025
3.2.2 Global Dutasteride Soft Capsules Sales by Region: 2026-2031
3.3 Global Dutasteride Soft Capsules Revenue by Region: 2020-2031
3.3.1 Global Dutasteride Soft Capsules Revenue by Region: 2020-2025
3.3.2 Global Dutasteride Soft Capsules Revenue by Region: 2026-2031
3.4 North America Dutasteride Soft Capsules Market Facts & Figures by Country
3.4.1 North America Dutasteride Soft Capsules Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Dutasteride Soft Capsules Sales by Country (2020-2031)
3.4.3 North America Dutasteride Soft Capsules Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dutasteride Soft Capsules Market Facts & Figures by Country
3.5.1 Europe Dutasteride Soft Capsules Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Dutasteride Soft Capsules Sales by Country (2020-2031)
3.5.3 Europe Dutasteride Soft Capsules Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dutasteride Soft Capsules Market Facts & Figures by Region
3.6.1 Asia Pacific Dutasteride Soft Capsules Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Dutasteride Soft Capsules Sales by Region (2020-2031)
3.6.3 Asia Pacific Dutasteride Soft Capsules Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Dutasteride Soft Capsules Market Facts & Figures by Country
3.7.1 Latin America Dutasteride Soft Capsules Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Dutasteride Soft Capsules Sales by Country (2020-2031)
3.7.3 Latin America Dutasteride Soft Capsules Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dutasteride Soft Capsules Market Facts & Figures by Country
3.8.1 Middle East and Africa Dutasteride Soft Capsules Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Dutasteride Soft Capsules Sales by Country (2020-2031)
3.8.3 Middle East and Africa Dutasteride Soft Capsules Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dutasteride Soft Capsules Sales by Type (2020-2031)
4.1.1 Global Dutasteride Soft Capsules Sales by Type (2020-2025)
4.1.2 Global Dutasteride Soft Capsules Sales by Type (2026-2031)
4.1.3 Global Dutasteride Soft Capsules Sales Market Share by Type (2020-2031)
4.2 Global Dutasteride Soft Capsules Revenue by Type (2020-2031)
4.2.1 Global Dutasteride Soft Capsules Revenue by Type (2020-2025)
4.2.2 Global Dutasteride Soft Capsules Revenue by Type (2026-2031)
4.2.3 Global Dutasteride Soft Capsules Revenue Market Share by Type (2020-2031)
4.3 Global Dutasteride Soft Capsules Price by Type (2020-2031)
5 Segment by Application
5.1 Global Dutasteride Soft Capsules Sales by Application (2020-2031)
5.1.1 Global Dutasteride Soft Capsules Sales by Application (2020-2025)
5.1.2 Global Dutasteride Soft Capsules Sales by Application (2026-2031)
5.1.3 Global Dutasteride Soft Capsules Sales Market Share by Application (2020-2031)
5.2 Global Dutasteride Soft Capsules Revenue by Application (2020-2031)
5.2.1 Global Dutasteride Soft Capsules Revenue by Application (2020-2025)
5.2.2 Global Dutasteride Soft Capsules Revenue by Application (2026-2031)
5.2.3 Global Dutasteride Soft Capsules Revenue Market Share by Application (2020-2031)
5.3 Global Dutasteride Soft Capsules Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Jiangsu Hengrui Pharmaceuticals Co.,ltd.
6.1.1 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Company Information
6.1.2 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Description and Business Overview
6.1.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Dutasteride Soft Capsules Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Dutasteride Soft Capsules Product Portfolio
6.1.5 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Recent Developments/Updates
6.2 GlaxoSmithKline plc
6.2.1 GlaxoSmithKline plc Company Information
6.2.2 GlaxoSmithKline plc Description and Business Overview
6.2.3 GlaxoSmithKline plc Dutasteride Soft Capsules Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GlaxoSmithKline plc Dutasteride Soft Capsules Product Portfolio
6.2.5 GlaxoSmithKline plc Recent Developments/Updates
6.3 Sichuan Gowell Pharmaceutical Co., Ltd.
6.3.1 Sichuan Gowell Pharmaceutical Co., Ltd. Company Information
6.3.2 Sichuan Gowell Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Sichuan Gowell Pharmaceutical Co., Ltd. Dutasteride Soft Capsules Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sichuan Gowell Pharmaceutical Co., Ltd. Dutasteride Soft Capsules Product Portfolio
6.3.5 Sichuan Gowell Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 Puracap Pharmaceuticals
6.4.1 Puracap Pharmaceuticals Company Information
6.4.2 Puracap Pharmaceuticals Description and Business Overview
6.4.3 Puracap Pharmaceuticals Dutasteride Soft Capsules Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Puracap Pharmaceuticals Dutasteride Soft Capsules Product Portfolio
6.4.5 Puracap Pharmaceuticals Recent Developments/Updates
6.5 Qilu Pharmaceutical Co., Ltd
6.5.1 Qilu Pharmaceutical Co., Ltd Company Information
6.5.2 Qilu Pharmaceutical Co., Ltd Description and Business Overview
6.5.3 Qilu Pharmaceutical Co., Ltd Dutasteride Soft Capsules Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Qilu Pharmaceutical Co., Ltd Dutasteride Soft Capsules Product Portfolio
6.5.5 Qilu Pharmaceutical Co., Ltd Recent Developments/Updates
6.6 Rivopharm UK Ltd
6.6.1 Rivopharm UK Ltd Company Information
6.6.2 Rivopharm UK Ltd Description and Business Overview
6.6.3 Rivopharm UK Ltd Dutasteride Soft Capsules Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Rivopharm UK Ltd Dutasteride Soft Capsules Product Portfolio
6.6.5 Rivopharm UK Ltd Recent Developments/Updates
6.7 DM Pharma Marketing Pvt Ltd
6.7.1 DM Pharma Marketing Pvt Ltd Company Information
6.7.2 DM Pharma Marketing Pvt Ltd Description and Business Overview
6.7.3 DM Pharma Marketing Pvt Ltd Dutasteride Soft Capsules Sales, Revenue and Gross Margin (2020-2025)
6.7.4 DM Pharma Marketing Pvt Ltd Dutasteride Soft Capsules Product Portfolio
6.7.5 DM Pharma Marketing Pvt Ltd Recent Developments/Updates
6.8 Mega Lifesciences
6.8.1 Mega Lifesciences Company Information
6.8.2 Mega Lifesciences Description and Business Overview
6.8.3 Mega Lifesciences Dutasteride Soft Capsules Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Mega Lifesciences Dutasteride Soft Capsules Product Portfolio
6.8.5 Mega Lifesciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dutasteride Soft Capsules Industry Chain Analysis
7.2 Dutasteride Soft Capsules Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dutasteride Soft Capsules Production Mode & Process Analysis
7.4 Dutasteride Soft Capsules Sales and Marketing
7.4.1 Dutasteride Soft Capsules Sales Channels
7.4.2 Dutasteride Soft Capsules Distributors
7.5 Dutasteride Soft Capsules Customer Analysis
8 Dutasteride Soft Capsules Market Dynamics
8.1 Dutasteride Soft Capsules Industry Trends
8.2 Dutasteride Soft Capsules Market Drivers
8.3 Dutasteride Soft Capsules Market Challenges
8.4 Dutasteride Soft Capsules Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Dutasteride Soft Capsules Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Dutasteride Soft Capsules Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Dutasteride Soft Capsules Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Dutasteride Soft Capsules Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Dutasteride Soft Capsules Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Dutasteride Soft Capsules Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Dutasteride Soft Capsules Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Dutasteride Soft Capsules Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Dutasteride Soft Capsules, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Dutasteride Soft Capsules, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Dutasteride Soft Capsules, Product Type & Application
 Table 12. Global Key Manufacturers of Dutasteride Soft Capsules, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Dutasteride Soft Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dutasteride Soft Capsules as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Dutasteride Soft Capsules Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Dutasteride Soft Capsules Sales by Region (2020-2025) & (K Units)
 Table 18. Global Dutasteride Soft Capsules Sales Market Share by Region (2020-2025)
 Table 19. Global Dutasteride Soft Capsules Sales by Region (2026-2031) & (K Units)
 Table 20. Global Dutasteride Soft Capsules Sales Market Share by Region (2026-2031)
 Table 21. Global Dutasteride Soft Capsules Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Dutasteride Soft Capsules Revenue Market Share by Region (2020-2025)
 Table 23. Global Dutasteride Soft Capsules Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Dutasteride Soft Capsules Revenue Market Share by Region (2026-2031)
 Table 25. North America Dutasteride Soft Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Dutasteride Soft Capsules Sales by Country (2020-2025) & (K Units)
 Table 27. North America Dutasteride Soft Capsules Sales by Country (2026-2031) & (K Units)
 Table 28. North America Dutasteride Soft Capsules Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Dutasteride Soft Capsules Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Dutasteride Soft Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Dutasteride Soft Capsules Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Dutasteride Soft Capsules Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Dutasteride Soft Capsules Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Dutasteride Soft Capsules Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Dutasteride Soft Capsules Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Dutasteride Soft Capsules Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Dutasteride Soft Capsules Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Dutasteride Soft Capsules Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Dutasteride Soft Capsules Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Dutasteride Soft Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Dutasteride Soft Capsules Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Dutasteride Soft Capsules Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Dutasteride Soft Capsules Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Dutasteride Soft Capsules Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Dutasteride Soft Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Dutasteride Soft Capsules Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Dutasteride Soft Capsules Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Dutasteride Soft Capsules Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Dutasteride Soft Capsules Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Dutasteride Soft Capsules Sales (K Units) by Type (2020-2025)
 Table 51. Global Dutasteride Soft Capsules Sales (K Units) by Type (2026-2031)
 Table 52. Global Dutasteride Soft Capsules Sales Market Share by Type (2020-2025)
 Table 53. Global Dutasteride Soft Capsules Sales Market Share by Type (2026-2031)
 Table 54. Global Dutasteride Soft Capsules Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Dutasteride Soft Capsules Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Dutasteride Soft Capsules Revenue Market Share by Type (2020-2025)
 Table 57. Global Dutasteride Soft Capsules Revenue Market Share by Type (2026-2031)
 Table 58. Global Dutasteride Soft Capsules Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Dutasteride Soft Capsules Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Dutasteride Soft Capsules Sales (K Units) by Application (2020-2025)
 Table 61. Global Dutasteride Soft Capsules Sales (K Units) by Application (2026-2031)
 Table 62. Global Dutasteride Soft Capsules Sales Market Share by Application (2020-2025)
 Table 63. Global Dutasteride Soft Capsules Sales Market Share by Application (2026-2031)
 Table 64. Global Dutasteride Soft Capsules Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Dutasteride Soft Capsules Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Dutasteride Soft Capsules Revenue Market Share by Application (2020-2025)
 Table 67. Global Dutasteride Soft Capsules Revenue Market Share by Application (2026-2031)
 Table 68. Global Dutasteride Soft Capsules Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Dutasteride Soft Capsules Price (US$/Unit) by Application (2026-2031)
 Table 70. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Company Information
 Table 71. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Description and Business Overview
 Table 72. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Dutasteride Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Dutasteride Soft Capsules Product
 Table 74. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Recent Developments/Updates
 Table 75. GlaxoSmithKline plc Company Information
 Table 76. GlaxoSmithKline plc Description and Business Overview
 Table 77. GlaxoSmithKline plc Dutasteride Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. GlaxoSmithKline plc Dutasteride Soft Capsules Product
 Table 79. GlaxoSmithKline plc Recent Developments/Updates
 Table 80. Sichuan Gowell Pharmaceutical Co., Ltd. Company Information
 Table 81. Sichuan Gowell Pharmaceutical Co., Ltd. Description and Business Overview
 Table 82. Sichuan Gowell Pharmaceutical Co., Ltd. Dutasteride Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Sichuan Gowell Pharmaceutical Co., Ltd. Dutasteride Soft Capsules Product
 Table 84. Sichuan Gowell Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 85. Puracap Pharmaceuticals Company Information
 Table 86. Puracap Pharmaceuticals Description and Business Overview
 Table 87. Puracap Pharmaceuticals Dutasteride Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Puracap Pharmaceuticals Dutasteride Soft Capsules Product
 Table 89. Puracap Pharmaceuticals Recent Developments/Updates
 Table 90. Qilu Pharmaceutical Co., Ltd Company Information
 Table 91. Qilu Pharmaceutical Co., Ltd Description and Business Overview
 Table 92. Qilu Pharmaceutical Co., Ltd Dutasteride Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Qilu Pharmaceutical Co., Ltd Dutasteride Soft Capsules Product
 Table 94. Qilu Pharmaceutical Co., Ltd Recent Developments/Updates
 Table 95. Rivopharm UK Ltd Company Information
 Table 96. Rivopharm UK Ltd Description and Business Overview
 Table 97. Rivopharm UK Ltd Dutasteride Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Rivopharm UK Ltd Dutasteride Soft Capsules Product
 Table 99. Rivopharm UK Ltd Recent Developments/Updates
 Table 100. DM Pharma Marketing Pvt Ltd Company Information
 Table 101. DM Pharma Marketing Pvt Ltd Description and Business Overview
 Table 102. DM Pharma Marketing Pvt Ltd Dutasteride Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. DM Pharma Marketing Pvt Ltd Dutasteride Soft Capsules Product
 Table 104. DM Pharma Marketing Pvt Ltd Recent Developments/Updates
 Table 105. Mega Lifesciences Company Information
 Table 106. Mega Lifesciences Description and Business Overview
 Table 107. Mega Lifesciences Dutasteride Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Mega Lifesciences Dutasteride Soft Capsules Product
 Table 109. Mega Lifesciences Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Dutasteride Soft Capsules Distributors List
 Table 113. Dutasteride Soft Capsules Customers List
 Table 114. Dutasteride Soft Capsules Market Trends
 Table 115. Dutasteride Soft Capsules Market Drivers
 Table 116. Dutasteride Soft Capsules Market Challenges
 Table 117. Dutasteride Soft Capsules Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Dutasteride Soft Capsules
 Figure 2. Global Dutasteride Soft Capsules Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Dutasteride Soft Capsules Market Share by Type: 2024 & 2031
 Figure 4. Generic Drugs Product Picture
 Figure 5. Original Drugs Product Picture
 Figure 6. Global Dutasteride Soft Capsules Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Dutasteride Soft Capsules Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Other
 Figure 11. Global Dutasteride Soft Capsules Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Dutasteride Soft Capsules Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Dutasteride Soft Capsules Sales (2020-2031) & (K Units)
 Figure 14. Global Dutasteride Soft Capsules Average Price (US$/Unit) & (2020-2031)
 Figure 15. Dutasteride Soft Capsules Report Years Considered
 Figure 16. Dutasteride Soft Capsules Sales Share by Manufacturers in 2024
 Figure 17. Global Dutasteride Soft Capsules Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Dutasteride Soft Capsules Players: Market Share by Revenue in Dutasteride Soft Capsules in 2024
 Figure 19. Dutasteride Soft Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Dutasteride Soft Capsules Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Dutasteride Soft Capsules Sales Market Share by Country (2020-2031)
 Figure 22. North America Dutasteride Soft Capsules Revenue Market Share by Country (2020-2031)
 Figure 23. United States Dutasteride Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Dutasteride Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Dutasteride Soft Capsules Sales Market Share by Country (2020-2031)
 Figure 26. Europe Dutasteride Soft Capsules Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Dutasteride Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Dutasteride Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Dutasteride Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Dutasteride Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Dutasteride Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Dutasteride Soft Capsules Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Dutasteride Soft Capsules Revenue Market Share by Region (2020-2031)
 Figure 34. China Dutasteride Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Dutasteride Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Dutasteride Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Dutasteride Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Dutasteride Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Dutasteride Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Dutasteride Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Dutasteride Soft Capsules Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Dutasteride Soft Capsules Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Dutasteride Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Dutasteride Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Dutasteride Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Dutasteride Soft Capsules Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Dutasteride Soft Capsules Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Dutasteride Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Dutasteride Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Dutasteride Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Dutasteride Soft Capsules by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Dutasteride Soft Capsules by Type (2020-2031)
 Figure 53. Global Dutasteride Soft Capsules Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Dutasteride Soft Capsules by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Dutasteride Soft Capsules by Application (2020-2031)
 Figure 56. Global Dutasteride Soft Capsules Price (US$/Unit) by Application (2020-2031)
 Figure 57. Dutasteride Soft Capsules Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS